The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Floxapen 2000 mg powder for solution for injection or infusion

Teva B.V.PA1986/111/004

Main Information

Trade NameFloxapen 2000 mg powder for solution for injection or infusion
Active SubstancesFlucloxacillin
Dosage FormPowder for solution for injection/infusion
Licence HolderTeva B.V.
Licence NumberPA1986/111/004

Group Information

ATC CodeJ01CF Beta-lactamase resistant penicillins
J01CF05 flucloxacillin


License statusAuthorised
Licence Issued03/08/2012
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back